Results 211 to 220 of about 138,715 (220)
Some of the next articles are maybe not open access.
Age-related macular degeneration
Aging Clinical and Experimental Research, 1993Age-related macular degeneration (AMD), a bilateral, progressive macular disease, represents the major cause of blindness among elderly people living in Western countries. Clinical features of AMD vary from the initial asymptomatic aspects, drusen and retinal pigment epithelium alterations, to severe atrophic or exudative changes in the advanced stages,
T, Segato, E, Midena, M C, Blarzino
openaire +2 more sources
Age-related macular degeneration
The Lancet, 2018Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary changes) to late-stage (neovascular and atrophic). Age-related macular degeneration is a multifactorial disorder, with dysregulation in the complement, lipid, angiogenic,
Paul, Mitchell +3 more
openaire +2 more sources
Age-related macular degeneration
NursingAbstract: Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients age 50 and older, with an estimated 200 million people affected worldwide and a projected 288 million by 2040. This article provides an overview of the epidemiology, risk factors, pathophysiology, clinical manifestations, diagnosis ...
openaire +2 more sources
Cystoid Macular Degeneration in Exudative Age-Related Macular Degeneration
American Journal of Ophthalmology, 2011To investigate the prevalence and clinical significance of cystoid macular degeneration in eyes that underwent intravitreal ranibizumab injections for exudative age-related macular degeneration.Retrospective, interventional case series.We reviewed the charts of 56 consecutive patients (19 male, 37 female; mean age ± standard deviation, 80.81 ± 4.8 ...
QUERQUES , GIUSEPPE +5 more
openaire +5 more sources
Neovascular Age-Related Macular Degeneration
Ophthalmologica, 2012<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele +2 more
openaire +3 more sources
Age-Related Macular Degeneration
Primary Care: Clinics in Office Practice, 2015Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly. AMD is diagnosed based on characteristic retinal findings in individuals older than 50. Early detection and treatment are critical in increasing the likelihood of retaining good and functional vision.
openaire +2 more sources
Age related macular degeneration.
Clinical evidence, 2002Jennifer, Arnold, Shirley, Sarks
openaire +7 more sources
Age-related macular degeneration
British Journal of Hospital Medicine, 2016B B, Ong, F G, Ah-Fat
openaire +2 more sources
Age-Related Macular Degeneration
New England Journal of Medicine, 2000S L, Fine +3 more
openaire +2 more sources